Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Acquired MTAP Loss Following Entrectinib Resistance in ROS1‐Rearranged NSCLC With CD74 Exon 3–ROS1 Exon 34 Fusion

by Haraguchi Hashiguchi, Mizuha , Yoneda, Suzuyuki , Nakamura, Kohei , Fukunaga, Koichi , Asaoka, Masato , Nishihara, Hiroshi , Katayama, Makoto , Tanino, Maika , Kagyo, Junko , Terai, Hideki

in Antigens, Differentiation, B-Lymphocyte - genetics / Antimitotic agents / Antineoplastic agents / Benzamides - pharmacology / Benzamides - therapeutic use / Carcinoma, Non-Small-Cell Lung - drug therapy / Carcinoma, Non-Small-Cell Lung - genetics / Carcinoma, Non-Small-Cell Lung - pathology / Drug Resistance, Neoplasm - genetics / Exons / Female / Gene Rearrangement / Histocompatibility Antigens Class II - genetics / Humans / Indazoles - pharmacology / Indazoles - therapeutic use / Lung Neoplasms - drug therapy / Lung Neoplasms - genetics / Lung Neoplasms - pathology / Male / Middle Aged / Oncogene Proteins, Fusion - genetics / Protein-Tyrosine Kinases - genetics / Proto-Oncogene Proteins - genetics

2025

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Acquired MTAP Loss Following Entrectinib Resistance in ROS1‐Rearranged NSCLC With CD74 Exon 3–ROS1 Exon 34 Fusion

by Haraguchi Hashiguchi, Mizuha , Yoneda, Suzuyuki , Nakamura, Kohei , Fukunaga, Koichi , Asaoka, Masato , Nishihara, Hiroshi , Katayama, Makoto , Tanino, Maika , Kagyo, Junko , Terai, Hideki

2025

Confirm

Do you wish to request the book?

Acquired MTAP Loss Following Entrectinib Resistance in ROS1‐Rearranged NSCLC With CD74 Exon 3–ROS1 Exon 34 Fusion

by Haraguchi Hashiguchi, Mizuha , Yoneda, Suzuyuki , Nakamura, Kohei , Fukunaga, Koichi , Asaoka, Masato , Nishihara, Hiroshi , Katayama, Makoto , Tanino, Maika , Kagyo, Junko , Terai, Hideki

2025

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Acquired MTAP Loss Following Entrectinib Resistance in ROS1‐Rearranged NSCLC With CD74 Exon 3–ROS1 Exon 34 Fusion

Haraguchi Hashiguchi, Mizuha,

Yoneda, Suzuyuki,

Nakamura, Kohei,

Fukunaga, Koichi,

Asaoka, Masato,

Nishihara, Hiroshi,

Katayama, Makoto,

Tanino, Maika,

Kagyo, Junko,

Terai, Hideki

2025

Overview

This case highlights acquired MTAP loss during disease progression in ROS1‐rearranged NSCLC. Despite persistent CD74–ROS1 fusion and absence of known resistance mutations, the patient developed CNS progression after entrectinib, underscoring the value of longitudinal genomic profiling in guiding treatment decisions.

Share this book

Add to My Shelf

Publisher

John Wiley & Sons Australia, Ltd,John Wiley & Sons, Inc,Wiley

Subject

Antigens, Differentiation, B-Lymphocyte - genetics

/ Antimitotic agents

/ Antineoplastic agents

/ Benzamides - pharmacology

/ Benzamides - therapeutic use

/ Carcinoma, Non-Small-Cell Lung - drug therapy

/ Carcinoma, Non-Small-Cell Lung - genetics